Study of an anti-inflammatory pill for heart artery health
Part of Heart & circulation clinical trials.
This trial tests a pill that may reduce inflammation in blood vessels, which could lower the risk of heart attacks or strokes in people with atherosclerosis. It could help if you have plaque in your arteries and are at risk for major heart events.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have confirmed atherosclerosis, which is narrowing of your arteries due to plaque buildup.
- A specialist will check a special scan to see if you have high levels of inflammation in your arteries.
- Your heart disease must be stable, and you must be on standard medications or have had a procedure to open your arteries.
- You must be able to have a safe heart rhythm, with no uncontrolled heart rhythm problems or severe heart failure.
- You cannot have a current infection like hepatitis B, C, or HIV, or a history of recent cancer or major surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a mindfulness (stress-reducing) program can lower “vascular inflammation” (inflammation in blood vessel walls) in people with stable coronary disease. It may help by improving stress and related inflammation markers while you stay on your usual heart medicines.
This trial tests a new medication called ABP-745 to see if it helps people with atherosclerosis (hardening of the arteries). It is for people who are already taking a cholesterol-lowering medicine and who have had a special heart artery X-ray (coronary angiography).
This trial tests whether two medicines, a statin and colchicine, can slow or stop early heart artery plaque from growing in people who have mild plaque but no heart disease symptoms yet. It uses special CT scans to measure plaque over 2 years.
This study tests a new medicine called YMI024 for people with stable coronary artery disease (blockages in heart arteries) and higher than normal levels of inflammation. The drug aims to reduce inflammation and may lower the risk of future heart problems.
This study tests a new medication called selatogrel in people with chronic coronary syndrome (long-term heart disease caused by narrowed heart arteries). Researchers want to see how the body processes this drug and whether it helps prevent future heart problems.
This study tests an investigational medicine called HRS9531 for people with atherosclerotic cardiovascular disease (a buildup of plaque in the arteries that can lead to heart attacks and strokes). The trial aims to see if the medicine helps reduce risks in this condition.
Hear when a new Atherosclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.